(Q53447388)

14 May 2018

title

A brief history of calcitonin. (English)

1 reference

14 May 2018

author name string

Eric Colman

1

1 reference

14 May 2018

Randy Hedin

2

1 reference

14 May 2018

Joslyn Swann

3

1 reference

14 May 2018

David Orloff

4

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

14 May 2018

published in

The Lancet

1 reference

14 May 2018

volume

359

1 reference

14 May 2018

issue

9309

1 reference

14 May 2018

page(s)

885-886

1 reference

14 May 2018

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Thyrocalcitonin: inhibitor of bone resorption in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Calcium Metabolism and 47Calcium Kinetics before and after Long-Term Thyrocalcitonin Treatment in Senile Osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Effects of Porcine Calcitonin on Calcium Metabolism in Osteoporosis*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Long-term calcitonin therapy in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

What PROOF proves about calcitonin and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

Osteoporosis prevention, diagnosis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907949-7

7 January 2021

10.1016/S0140-6736(02)07949-7

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

11897305

1 reference

14 May 2018